Review



human complement fragment 5a des arg  (Hycult Biotech)


Bioz Verified Symbol Hycult Biotech is a verified supplier
Bioz Manufacturer Symbol Hycult Biotech manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Hycult Biotech human complement fragment 5a des arg
    Human Complement Fragment 5a Des Arg, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 90/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human complement fragment 5a des arg/product/Hycult Biotech
    Average 90 stars, based on 2 article reviews
    human complement fragment 5a des arg - by Bioz Stars, 2026-02
    90/100 stars

    Images



    Similar Products

    human complement fragment 5a des arg  (Hycult Biotech)
    90
    Hycult Biotech human complement fragment 5a des arg
    Human Complement Fragment 5a Des Arg, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human complement fragment 5a des arg/product/Hycult Biotech
    Average 90 stars, based on 1 article reviews
    human complement fragment 5a des arg - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    human recombinant c5a desarg  (Hycult Biotech)
    90
    Hycult Biotech human recombinant c5a desarg
    ( A ) Serial dilutions of native, human <t>C3a-desArg</t> (black circle), recombinant, human <t>C5a-desArg</t> (black square) and native human sC5b-C9 (black triangle) depicted different assay performances for the simultaneous analysis of complement activation markers. The target antigens were only detected by respective coupled magnetic beads and not by control beads (grey). Limit of detection (orange) and assay cutoffs (red square) for each analyte are shown. ( B ) The concentration range of complement activation markers determined with the novel multiplex assay from a human serum pool (black square with dot) corresponded to previously reported ranges for C3a, C5a and sC5b-C9 single detection either from plasma (grey), serum (black) or unknown sample matrix (white), respectively [ – ].
    Human Recombinant C5a Desarg, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human recombinant c5a desarg/product/Hycult Biotech
    Average 90 stars, based on 1 article reviews
    human recombinant c5a desarg - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    c5a desarg  (Hycult Biotech)
    90
    Hycult Biotech c5a desarg
    ( A ) Serial dilutions of native, human <t>C3a-desArg</t> (black circle), recombinant, human <t>C5a-desArg</t> (black square) and native human sC5b-C9 (black triangle) depicted different assay performances for the simultaneous analysis of complement activation markers. The target antigens were only detected by respective coupled magnetic beads and not by control beads (grey). Limit of detection (orange) and assay cutoffs (red square) for each analyte are shown. ( B ) The concentration range of complement activation markers determined with the novel multiplex assay from a human serum pool (black square with dot) corresponded to previously reported ranges for C3a, C5a and sC5b-C9 single detection either from plasma (grey), serum (black) or unknown sample matrix (white), respectively [ – ].
    C5a Desarg, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c5a desarg/product/Hycult Biotech
    Average 90 stars, based on 1 article reviews
    c5a desarg - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    recombinant human c5a desarg  (Hycult Biotech)
    90
    Hycult Biotech recombinant human c5a desarg
    NOX-D20 binds to C5 but does not inhibit complement-mediated hemolysis. SPR measurement of NOX-D20 binding to human ( a ) <t>C5a,</t> ( b ) <t>C5a(desArg),</t> and ( c ) C5. Kinetic rate constants k a and k d are shown as mean ± SEM. Data are representative for at least three individual measurements. ( d ) Human serum pretreated with NOX-D20 (black squares) or C5-binding aptamer C5C6 (black triangles) was incubated with opsonized sheep erythrocytes. Hemolysis was quantified by photometric measurement of hemoglobin in the supernatant at 405 nm. Normalized data representative for three independent experiments is shown. RU, response units.
    Recombinant Human C5a Desarg, supplied by Hycult Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant human c5a desarg/product/Hycult Biotech
    Average 90 stars, based on 1 article reviews
    recombinant human c5a desarg - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    ( A ) Serial dilutions of native, human C3a-desArg (black circle), recombinant, human C5a-desArg (black square) and native human sC5b-C9 (black triangle) depicted different assay performances for the simultaneous analysis of complement activation markers. The target antigens were only detected by respective coupled magnetic beads and not by control beads (grey). Limit of detection (orange) and assay cutoffs (red square) for each analyte are shown. ( B ) The concentration range of complement activation markers determined with the novel multiplex assay from a human serum pool (black square with dot) corresponded to previously reported ranges for C3a, C5a and sC5b-C9 single detection either from plasma (grey), serum (black) or unknown sample matrix (white), respectively [ – ].

    Journal: Oncotarget

    Article Title: A novel multiplex detection array revealed systemic complement activation in oral squamous cell carcinoma

    doi: 10.18632/oncotarget.22963

    Figure Lengend Snippet: ( A ) Serial dilutions of native, human C3a-desArg (black circle), recombinant, human C5a-desArg (black square) and native human sC5b-C9 (black triangle) depicted different assay performances for the simultaneous analysis of complement activation markers. The target antigens were only detected by respective coupled magnetic beads and not by control beads (grey). Limit of detection (orange) and assay cutoffs (red square) for each analyte are shown. ( B ) The concentration range of complement activation markers determined with the novel multiplex assay from a human serum pool (black square with dot) corresponded to previously reported ranges for C3a, C5a and sC5b-C9 single detection either from plasma (grey), serum (black) or unknown sample matrix (white), respectively [ – ].

    Article Snippet: A mixture of serial 1:3 diluted human native C3a-desArg (197.5–0.001 ng/mL, cat. HC2127, Hycult Biotech, Beutelsbach, Germany), human recombinant C5a-desArg (28.1–0.004 ng/mL, Hycult Biotech, Beutelsbach, Germany) and human native sC5b-9 (66.6–0.0004 µg/mL, cat. A127, Complement Technology, Tyler, TX, USA) were used as standard curve.

    Techniques: Recombinant, Activation Assay, Magnetic Beads, Concentration Assay, Multiplex Assay

    ( A ) Serial dilutions of native, human C3a-desArg (black circle), recombinant, human C5a-desArg (black square) and native human sC5b-C9 (black triangle) depicted different assay performances for the simultaneous analysis of complement activation markers. The target antigens were only detected by respective coupled magnetic beads and not by control beads (grey). Limit of detection (orange) and assay cutoffs (red square) for each analyte are shown. ( B ) The concentration range of complement activation markers determined with the novel multiplex assay from a human serum pool (black square with dot) corresponded to previously reported ranges for C3a, C5a and sC5b-C9 single detection either from plasma (grey), serum (black) or unknown sample matrix (white), respectively [ – ].

    Journal: Oncotarget

    Article Title: A novel multiplex detection array revealed systemic complement activation in oral squamous cell carcinoma

    doi: 10.18632/oncotarget.22963

    Figure Lengend Snippet: ( A ) Serial dilutions of native, human C3a-desArg (black circle), recombinant, human C5a-desArg (black square) and native human sC5b-C9 (black triangle) depicted different assay performances for the simultaneous analysis of complement activation markers. The target antigens were only detected by respective coupled magnetic beads and not by control beads (grey). Limit of detection (orange) and assay cutoffs (red square) for each analyte are shown. ( B ) The concentration range of complement activation markers determined with the novel multiplex assay from a human serum pool (black square with dot) corresponded to previously reported ranges for C3a, C5a and sC5b-C9 single detection either from plasma (grey), serum (black) or unknown sample matrix (white), respectively [ – ].

    Article Snippet: Purified recombinant human C3a-desArg (1 µg, HC2127), C5a-desArg (1 µg, HC2102, Hycult Biotech, Beutelsbach, Germany), sC5b-9 (1 µg/0.1 µg, A127, Complement Technology, Tyler, TX, USA) or normal human serum (20 µg, NHS) were separated under reducing and non-reducing conditions in either 10% or 15% SDS-PAGE and subsequently transferred to polyvinylidene difluoride membranes.

    Techniques: Recombinant, Activation Assay, Magnetic Beads, Concentration Assay, Multiplex Assay

    NOX-D20 binds to C5 but does not inhibit complement-mediated hemolysis. SPR measurement of NOX-D20 binding to human ( a ) C5a, ( b ) C5a(desArg), and ( c ) C5. Kinetic rate constants k a and k d are shown as mean ± SEM. Data are representative for at least three individual measurements. ( d ) Human serum pretreated with NOX-D20 (black squares) or C5-binding aptamer C5C6 (black triangles) was incubated with opsonized sheep erythrocytes. Hemolysis was quantified by photometric measurement of hemoglobin in the supernatant at 405 nm. Normalized data representative for three independent experiments is shown. RU, response units.

    Journal: Molecular Therapy

    Article Title: A Novel C5a-neutralizing Mirror-image ( l -)Aptamer Prevents Organ Failure and Improves Survival in Experimental Sepsis

    doi: 10.1038/mt.2013.178

    Figure Lengend Snippet: NOX-D20 binds to C5 but does not inhibit complement-mediated hemolysis. SPR measurement of NOX-D20 binding to human ( a ) C5a, ( b ) C5a(desArg), and ( c ) C5. Kinetic rate constants k a and k d are shown as mean ± SEM. Data are representative for at least three individual measurements. ( d ) Human serum pretreated with NOX-D20 (black squares) or C5-binding aptamer C5C6 (black triangles) was incubated with opsonized sheep erythrocytes. Hemolysis was quantified by photometric measurement of hemoglobin in the supernatant at 405 nm. Normalized data representative for three independent experiments is shown. RU, response units.

    Article Snippet: Recombinant human and mouse C5a was from R&D Systems (Wiesbaden, Germany), recombinant human C5a(desArg) from Hycult Biotech (Beutelsbach, Germany), and human C5 purified from serum from Sigma-Aldrich (Taufkirchen, Germany).

    Techniques: Binding Assay, Incubation